New Square Capital LLC Pds Biotechnology Corp Transaction History
New Square Capital LLC
- $1.23 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
59Shares Held
4.22MCall Options Held
170KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.91 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$618,4480.0% of portfolio
-
Geode Capital Management, LLC Boston, MA417KShares$529,8650.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA247KShares$313,6600.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il220KShares$279,6730.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $36.1M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...